The simultaneous role as both a marker of disease course and a risk factor for NDDs, i.e., the APOe4 polymorphism for Alzheimer’s disease, proposed on the basis of well-known associations with genetic and vascular disorders, constitutes a fundamental feature of the driver model (de Pedro-Cuesta et al., 2016a). This evidence concerns the gene APOE and Alzheimer disease.